Allisone
2 known investors
Find your way into Allisone
377 people in our graph share verified history with the Allisone team — schools, employers, funds. One of them is your warm intro.
Sauvanne Saint-Légerunlockedknows Sacha Samama · together at University of Paris I: Panthéon-Sorbonne (overlapped)
×3knows the team · via Université Denis Diderot (Paris VII)
×6knows the team · via University of Paris I: Panthéon-Sorbonne
knows the team · via Abercrombie & Fitch
knows the team · via Université Paris 13
Allisone is an AI medical device software (SaaS) for dentists that provides diagnostic support by analyzing dental X-rays, detecting pathologies such as caries and periapical lesions, and recognizing implants to improve patient communication and treatment acceptance. Its data is stored on an HDS-certified cloud platform in France, serving dental practices across Europe.
Founders & leadership
SS
Sacha SamamainFounderSacha Samama spent four years in AI consulting and subsequently developed an AI Engineer bootcamp before founding Allisone, where he led the technical development of AI diagnostic software for dental X-ray analysis. His background spans applied AI systems in regulated domains including finance, legal, and healthcare.
LE
Lionel ElbazinFounderLionel Elbaz is a dentist who built and exited a 20+ clinic dental services organization in France valued at €80M+. He now leads Allisone, an AI-powered diagnostic platform for dental practices.
Investors · 2
Competitors · 3
by search overlap
Pearl14 shared keywordsPearl develops FDA-cleared AI software that reads dental x-rays in real time, helping dentists detect cavities and other pathologies and show patients the evidence behind a diagnosis. Founded in 2019 by Ophir Tanz as a spinout of his computer-vision company GumGum, the Los Angeles-based company holds more than two dozen FDA clearances, and its Second Opinion and Practice Intelligence platforms are used by dental practices in over 120 countries. Pearl raised a $58 million Series B led by Left Lane Capital in July 2024, the largest funding round in dental AI at the time.
Denti11 shared keywordsDenti.AI develops artificial intelligence technology for teeth pathology detection and clinical applications in dentistry. The company serves dental practices, dental school operators (DSOs), and dental professionals seeking diagnostic and workflow solutions powered by deep learning.
CareCloud9 shared keywordsCareCloud develops cloud-based software, revenue cycle management services, and AI-powered tools for healthcare providers ranging from small practices to large hospital systems. The company's offerings include electronic health records, practice management systems, medical billing and coding services, telemedicine, remote patient monitoring, healthcare staffing, and consulting services designed to optimize clinical workflows, financial performance, and patient engagement.
Companies competing with Allisone for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Allisone do?
- Allisone is an AI medical device software (SaaS) for dentists that provides diagnostic support by analyzing dental X-rays, detecting pathologies such as caries and periapical lesions, and recognizing implants to improve patient communication and treatment acceptance. Its data is stored on an HDS-certified cloud platform in France, serving dental practices across Europe.
- Who founded Allisone?
- Allisone was founded by Sacha Samama, Lionel Elbaz.
- Who are Allisone's investors?
- Allisone's investors include Kima Ventures, Samaipata.